218 related articles for article (PubMed ID: 33760180)
21. Expression and functional implications of YME1L in nasopharyngeal carcinoma.
Cheng F; Huang H; Yin S; Liu JS; Sun P
Cell Death Dis; 2024 Jun; 15(6):423. PubMed ID: 38890304
[TBL] [Abstract][Full Text] [Related]
22. Homeodomain protein DLX4 facilitates nasopharyngeal carcinoma progression via up-regulation of YB-1.
Ling Z; Long X; Li J; Feng M
Genes Cells; 2020 Jul; 25(7):466-474. PubMed ID: 32281175
[TBL] [Abstract][Full Text] [Related]
23. miR-144-3p facilitates nasopharyngeal carcinoma via crosstalk with PTEN.
Song L; Chen L; Luan Q; Kong Q
J Cell Physiol; 2019 Aug; 234(10):17912-17924. PubMed ID: 30834525
[TBL] [Abstract][Full Text] [Related]
24. EBV-miR-BART8-3p induces epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma cells through activating NF-κB and Erk1/2 pathways.
Lin C; Zong J; Lin W; Wang M; Xu Y; Zhou R; Lin S; Guo Q; Chen H; Ye Y; Zhang B; Pan J
J Exp Clin Cancer Res; 2018 Nov; 37(1):283. PubMed ID: 30477559
[TBL] [Abstract][Full Text] [Related]
25. Upregulation of lncRNA HAGLROS enhances the development of nasopharyngeal carcinoma via modulating miR-100/ATG14 axis-mediated PI3K/AKT/mTOR signals.
Zhang W; Zhang Y; Xi S
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3043-3052. PubMed ID: 31334669
[TBL] [Abstract][Full Text] [Related]
26. Increased expression of lncRNA SNHG12 predicts a poor prognosis of nasopharyngeal carcinoma and regulates cell proliferation and metastasis by modulating Notch signal pathway.
Liu ZB; Tang C; Jin X; Liu SH; Pi W
Cancer Biomark; 2018; 23(4):603-613. PubMed ID: 30452404
[TBL] [Abstract][Full Text] [Related]
27. Annexin A1-suppressed autophagy promotes nasopharyngeal carcinoma cell invasion and metastasis by PI3K/AKT signaling activation.
Zhu JF; Huang W; Yi HM; Xiao T; Li JY; Feng J; Yi H; Lu SS; Li XH; Lu RH; He QY; Xiao ZQ
Cell Death Dis; 2018 Nov; 9(12):1154. PubMed ID: 30459351
[TBL] [Abstract][Full Text] [Related]
28. XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells.
Ji J; Yu Y; Li ZL; Chen MY; Deng R; Huang X; Wang GF; Zhang MX; Yang Q; Ravichandran S; Feng GK; Xu XL; Yang CL; Qiu MZ; Jiao L; Yang D; Zhu XF
Theranostics; 2018; 8(6):1494-1510. PubMed ID: 29556337
[No Abstract] [Full Text] [Related]
29. MiR-155 promotes proliferation and inhibits apoptosis of nasopharyngeal carcinoma cells through targeting PTEN-PI3K/AKT pathway.
Zuo WN; Zhu H; Li LP; Jin AY; Wang HQ
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7935-7942. PubMed ID: 31599418
[TBL] [Abstract][Full Text] [Related]
30. HDAC7 promotes the oncogenicity of nasopharyngeal carcinoma cells by miR-4465-EphA2 signaling axis.
Li QG; Xiao T; Zhu W; Yu ZZ; Huang XP; Yi H; Lu SS; Tang YY; Huang W; Xiao ZQ
Cell Death Dis; 2020 May; 11(5):322. PubMed ID: 32376822
[TBL] [Abstract][Full Text] [Related]
31. Reducing NETO2 expression prevents human nasopharyngeal carcinoma (NPC) progression by suppressing metastasis and inducing apoptosis.
He AR; Zhu Q; Gao S
Biochem Biophys Res Commun; 2019 May; 513(2):494-501. PubMed ID: 30975469
[TBL] [Abstract][Full Text] [Related]
32. Long noncoding RNA PTPRG-AS1 acts as a microRNA-194-3p sponge to regulate radiosensitivity and metastasis of nasopharyngeal carcinoma cells via PRC1.
Yi L; Ouyang L; Wang S; Li SS; Yang XM
J Cell Physiol; 2019 Aug; 234(10):19088-19102. PubMed ID: 30993702
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic hyperthermia regulates complement C3 activation and suppresses tumor development through HSPA5/NFκB/CD55 pathway in nasopharyngeal carcinoma.
Chen C; Ren A; Yi Q; Cai J; Khan M; Lin Y; Huang Z; Lin J; Zhang J; Liu W; Xu A; Tian Y; Yuan Y; Zheng R
Clin Exp Immunol; 2023 Jul; 213(2):221-234. PubMed ID: 37249005
[TBL] [Abstract][Full Text] [Related]
34. LncRNA XIST knockdown suppresses the malignancy of human nasopharyngeal carcinoma through XIST/miRNA-148a-3p/ADAM17 pathway in vitro and in vivo.
Shi J; Tan S; Song L; Song L; Wang Y
Biomed Pharmacother; 2020 Jan; 121():109620. PubMed ID: 31810117
[TBL] [Abstract][Full Text] [Related]
35. Circular RNA TGFBR2 acts as a ceRNA to suppress nasopharyngeal carcinoma progression by sponging miR-107.
Li W; Lu H; Wang H; Ning X; Liu Q; Zhang H; Liu Z; Wang J; Zhao W; Gu Y; Li H; Sun X; Hu L; Wang D
Cancer Lett; 2021 Feb; 499():301-313. PubMed ID: 33160003
[TBL] [Abstract][Full Text] [Related]
36. AIMP2-DX2 Promotes the Proliferation, Migration, and Invasion of Nasopharyngeal Carcinoma Cells.
Cao Q; Zhang J; Zhang T
Biomed Res Int; 2018; 2018():9253036. PubMed ID: 29854811
[TBL] [Abstract][Full Text] [Related]
37. CircCTDP1 promotes nasopharyngeal carcinoma progression via a microRNA‑320b/HOXA10/TGFβ2 pathway.
Li H; You J; Xue H; Tan X; Chao C
Int J Mol Med; 2020 Mar; 45(3):836-846. PubMed ID: 31985027
[TBL] [Abstract][Full Text] [Related]
38. Evodiamine inhibits the migration and invasion of nasopharyngeal carcinoma cells in vitro via repressing MMP-2 expression.
Peng X; Zhang Q; Zeng Y; Li J; Wang L; Ai P
Cancer Chemother Pharmacol; 2015 Dec; 76(6):1173-84. PubMed ID: 26546460
[TBL] [Abstract][Full Text] [Related]
39. Knockdown of long non-coding RNA TUG1 suppresses nasopharyngeal carcinoma progression by inhibiting epithelial-mesenchymal transition (EMT) via the promotion of miR-384.
Qian W; Ren Z; Lu X
Biochem Biophys Res Commun; 2019 Jan; 509(1):56-63. PubMed ID: 30581000
[TBL] [Abstract][Full Text] [Related]
40. Knockdown of Notch1 inhibits nasopharyngeal carcinoma cell growth and metastasis via downregulation of CCL2, CXCL16, and uPA.
Guo H; Wang F; Diao Y; Zhang Z; Chen Q; Qian CN; Keller ET; Zhang J; Lu Y
Mol Carcinog; 2019 Oct; 58(10):1886-1896. PubMed ID: 31270884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
